Health experts say that Fentanyl, an opioid drug, is now a crisis in Milwaukee Country due to its rising rates of death reports.
Food and Drug Administration finally gave out their go signal to produce the treatment drug for multiple sclerosis.
After four patients travelled to Uganda, they were treated with malaria drugs last year. After a year, malaria returned and showed signs of resistance to the drugs.
The U.S. Food and Drug Administration (FDA) agreed to speed up the review of Roche's Tecentriq, the immunotherapy drug intended for metastatic urothelial carcinoma.
Diclegis, a drug used for decades to treat morning sickness, has been endorsed by Kim Kardashian in 2015. Now, doctors are questioning its efficacy.
Glioblastoma Multiforme, the deadliest type of brain cancer, is very hard to treat because of its resistance to treatment. Now, a new treatment has been found by scientists.
Modafinil is sold in different brand names all over the world; Atomoxetine is among of those drugs tested by Vlaev's team. Atomoxetine has been used for ADHD, another form of impulsive conditions
Two new studies prove that clot-busting drug (tPA) potentially reduces the number of deaths linked to patients with hemorrhagic stroke.
A diabetes drug has been linked to lowering risk of heart attack and recurring stroke in non-diabetic patients, a new study found.
Adderall remains the most frequently misused ADHD medication.
John Hopkins-based scientists are working on a lab grown mini-replica of human brain in an attempt to understand brain diseases better and replace animal drug testing.
Galapagos NV announced that its experimental drug for bowel disease did not meet a significant Phase II mark.
Crucial positive findings on Zafgen’s experimental obesity medication, beloranib, raises hopes on reversing FDA’s suspension of its drug approval bid following two deaths during the clinical trials.
Alkermes Plc's depression drug failed to meet the primary endpoints in two late stage studies.
A French criminal investigation is underway following a failed drugs trial for Portuguese drug company Bial that resulted in one confirmed death and five serious hospitalizations.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.